Financhill
Sell
34

MRNA Quote, Financials, Valuation and Earnings

Last price:
$32.74
Seasonality move :
5%
Day range:
$32.14 - $34.97
52-week range:
$22.28 - $48.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.60x
P/B ratio:
1.35x
Volume:
11.9M
Avg. volume:
10.7M
1-year change:
-18.44%
Market cap:
$12.6B
Revenue:
$3.2B
EPS (TTM):
-$8.06

Earnings Data

Next earnings date for MRNA
Feb 12
2026
Most recent earnings per share
-$0.51
Beat by $1.65
(Nov 6/2025)
Consensus Estimate
-$2.16
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MRNA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/12/2026 Q4 $633.1M -- -- -$2.76 --
11/06/2025 Q3 $869.9M $1B -$0.51 -$2.16 $1.65
08/01/2025 Q2 $112.6M $142M -$2.13 -$3.00 $0.87
05/01/2025 Q1 $115.3M $108M -$2.52 -$3.11 $0.59
02/14/2025 Q4 $941.1M $966M -$2.91 -$2.73 -$0.18
11/07/2024 Q3 $1.2B $1.9B $0.03 -$1.94 $1.97
08/01/2024 Q2 $134.9M $241M -$3.33 -$3.36 $0.03
05/02/2024 Q1 $125.3M $167M -$3.08 -$3.55 $0.48
02/22/2024 Q4 $2.5B $2.8B $0.55 -$0.99 $1.54
11/02/2023 Q3 -- $1.8B -$9.53 -- --
06/30/2023 Q2 -- $344M -$3.62 -- --
03/31/2023 Q1 -- $1.9B $0.20 -- --
12/31/2022 Q4 -- $5B $3.62 -- --
09/30/2022 Q3 -- $3.3B $2.53 -- --
06/30/2022 Q2 -- $4.7B $5.24 -- --
03/31/2022 Q1 -- $6.1B $8.58 -- --
12/31/2021 Q4 -- $7.1B $11.29 -- --
09/30/2021 Q3 -- $5B $7.68 -- --
06/30/2021 Q2 -- $4.4B $6.45 -- --
03/31/2021 Q1 -- $1.9B $2.84 -- --
12/31/2020 Q4 -- $570.7M -$0.69 -- --
09/30/2020 Q3 -- $157.9M -$0.59 -- --
06/30/2020 Q2 -- $66.4M -$0.31 -- --
03/31/2020 Q1 -- $8.4M -$0.35 -- --
12/31/2019 Q4 -- $14.1M -$0.37 -- --
09/30/2019 Q3 -- $17M -$0.37 -- --
06/30/2019 Q2 -- $13.1M -$0.41 -- --
03/31/2019 Q1 -- $16M -$0.40 -- --
12/31/2018 Q4 -- $35.4M -$0.44 -- --
09/30/2018 Q3 -- $41.8M -$0.26 -- --
06/30/2018 Q2 -- $28.9M -$0.28 -- --
03/31/2018 Q1 -- $29M -$0.23 -- --
12/31/2017 Q4 -- $91.9M -$0.12 -- --
09/30/2017 Q3 -- $42.5M -$0.21 -- --

Moderna, Inc. Earnings Questions

  • How Much did Moderna, Inc. Generate in Revenue Last Quarter?

    Moderna, Inc. reported $1B worth of top line sales in its most recent quarter.

  • Did Moderna, Inc. Beat Earnings Last Quarter?

    Moderna, Inc. announced earnings per share of -$0.51 which represents a beat of analyst forecast a -$2.16 per share.

  • Is Moderna, Inc. Profitable?

    Moderna, Inc. reported $757M that represents $1.94 per share over the last quarter.

  • What is the Analyst Consensus for Moderna, Inc. EPS Next Year?

    Moderna, Inc.'s earnings are forecast to decrease from -$9.27 per share to -$9.03 per share next year representing a decrease of -12.24%.

  • When is Moderna, Inc.'s Earnings Date?

    Moderna, Inc.'s next earnings date is February 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock